Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
13.54
-0.07 (-0.51%)
Nov 17, 2026, 3:04 PM CST

SHE:300122 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
7,7628,86825,82452,91438,26030,629
Other Revenue
90.4290.42225.354.083.8523.46
7,8538,95826,04952,91838,26430,652
Revenue Growth
-28.00%-65.61%-50.77%38.30%24.83%101.79%
Cost of Revenue
20,82821,87418,96638,98625,51815,728
Gross Profit
-12,975-12,9167,08313,93212,74614,925
Selling, General & Admin
2,3792,8003,0613,1662,5952,121
Research & Development
933.06932.31,021968.47854.16552.63
Other Operating Expenses
52.8268.39138.91238.75177.02135.23
Operating Expenses
3,7264,2654,8284,7254,0473,000
Operating Income
-16,701-17,1812,2569,2068,69811,924
Interest Expense
-328.77-331.04-161.32-81-53.3-56.14
Interest & Investment Income
14.8624.6766.6967.9446.0961.47
Currency Exchange Gain (Loss)
10.9910.991.682.2815.4-10.1
Other Non Operating Income (Expenses)
-54.78-51.43-37.52-36.56-22.64-17.23
EBT Excluding Unusual Items
-17,059-17,5282,1259,1598,68411,902
Gain (Loss) on Sale of Investments
-8.76-14.220.24---5.63
Gain (Loss) on Sale of Assets
-0.035.880.0541.370.010.04
Asset Writedown
329.59-0.38-0.36-0.13-0.09-1.68
Other Unusual Items
27.434437.34142.3434.3135.83
Pretax Income
-16,710-17,4932,1639,3428,71811,931
Income Tax Expense
-2,601-2,747222.151,2721,1791,723
Earnings From Continuing Operations
-14,109-14,7451,9408,0707,53910,209
Minority Interest in Earnings
30.8222.1132---
Net Income
-14,079-14,7231,9728,0707,53910,209
Net Income to Common
-14,079-14,7231,9728,0707,53910,209
Net Income Growth
---75.56%7.04%-26.15%209.23%
Shares Outstanding (Basic)
2,3942,3942,3952,4002,4002,400
Shares Outstanding (Diluted)
2,3942,3942,3952,4002,4002,400
Shares Change
-0.07%-0.06%-0.20%---0.00%
EPS (Basic)
-5.88-6.150.823.363.144.25
EPS (Diluted)
-5.88-6.150.823.363.144.25
EPS Growth
---75.51%7.04%-26.15%209.23%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
5,6504,548-5,4257,862535.936,575
Free Cash Flow Per Share
2.361.90-2.273.280.222.74
Dividend Per Share
--0.2000.8000.3330.400
Dividend Growth
---75.00%140.02%-16.68%20.01%
Gross Margin
-165.23%-144.17%27.19%26.33%33.31%48.69%
Operating Margin
-212.67%-191.79%8.66%17.40%22.73%38.90%
Profit Margin
-179.28%-164.35%7.57%15.25%19.70%33.30%
Free Cash Flow Margin
71.95%50.77%-20.83%14.86%1.40%21.45%
EBITDA
-16,114-16,6822,6369,5189,00312,297
EBITDA Margin
-205.20%-186.22%10.12%17.99%23.53%40.12%
D&A For EBITDA
587.28498.71380.63311.85304.88372.24
EBIT
-16,701-17,1812,2569,2068,69811,924
EBIT Margin
-212.67%-191.79%8.66%17.40%22.73%38.90%
Effective Tax Rate
--10.27%13.62%13.52%14.44%
Revenue as Reported
7,8538,95826,04952,91838,26430,652
Advertising Expenses
-285.68395.28475.81395.05-